Polaris Partners
Polaris Partners
About
Key facts
- Portfolio companies
- 24
- Stages
- SeedSeries ASeries A-PlusSeries BSeries C
- Cheque size
- $3M to $250M
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 18 Mar 2026 | Crossbow Therapeutics | Series B | $77M |
| 1 Mar 2026 | Tropic | Series C | $91M |
| 3 Sept 2025 | Treeline Biosciences | Series B | $200M |
| 26 Jan 2025 | Invisible Technologies | Series B | $100M |
| 26 Oct 2024 | Fourth Power | Series A-Plus | $20M |
| 15 May 2024 | Orqai | Undisclosed round | $30M |
| 10 Nov 2021 | Cerebras | Undisclosed round | $250M |
| 3 Feb 2021 | Freenome | Series D | $300M |
| 19 Aug 2020 | Freenome | Series C | $270M |
| 4 Dec 2019 | Cerebras | Undisclosed round | $175M |
Write the first review
Frequently asked
What companies has Polaris Partners invested in?
Polaris Partners has invested in Crossbow Therapeutics, Tropic, Treeline Biosciences, Invisible Technologies, Fourth Power and 19 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Polaris Partners:
